Ozempic

• Could GLP-1 drugs help your mental health? New study finds a link

  Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.

  Health

  Mar 20
  
• Many regain weight after stopping GLP-1 drugs, data shows. Here’s why

  People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review of 63 trials covering over 9,000 individuals showed.

  Health

  Jan 8
  
• Advertisement
• Generic Ozempic can be made in Canada as of next week. Will it be cheaper?

  As of Dec. 29, Health Canada had received nine submissions seeking approval to make semaglutide, the active ingredient in Ozempic and Wegovy.

  Health

  Jan 2
• Advertisement
• Trump says prices for Ozempic, other weight-loss drugs to drop in U.S.

  Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.

  U.S. News

  Nov 6, 2025
• Ozempic, Wegovy makers Novo Nordisk announce 9K layoffs in restructuring

  Ozempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.

  World

  Sep 10, 2025
• Ozempic approved in Canada to reduce kidney decline in people with diabetes

  The patients taking the drug were also less likely to die from cardiovascular disease — another condition that affects many patients with diabetes.

  Health

  Aug 19, 2025
• University of Manitoba studies Ozempic marketing

  Researchers at the University of Manitoba are looking at how marketing for drugs like Ozempic and Wegovy influence peoples' views on food, hunger, and weight.

  Health

  Jul 23, 2025
• Ozempic, Wegovy linked to rare cases of eye disorder, EMA says

  Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.

  Consumer

  Jun 6, 2025
• Advertisement
• Drugs like Ozempic may lower cancer risk if you have diabetes: study

  Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

  Health

  May 23, 2025
• Advertisement
• Ozempic microdosing: Weight-loss hack or just a placebo?

  As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing. But experts have concerns.

  Health

  May 6, 2025